William Prueitt

William Prueitt is a Psychiatry Clinical Instructor at Yale School of Medicine, Yale University. His research focuses on psychedelic medicine, mental health, and neurodegenerative diseases. Key areas include developing educational programs in psychedelic therapies, investigating biomarkers for antidepressant efficacy (e.g., ketamine and esketamine), and understanding the impact of childhood maltreatment on depression outcomes. He has also contributed to studies on tau protein aggregates and neurodegenerative mechanisms.

His work bridges clinical psychiatry with biochemical research, particularly in glycosaminoglycan interactions with neurodegenerative proteins like tau. He maintains an active publication record, with notable contributions to Academic Psychiatry and Psychiatry Research.

Professional activities include designing curricula for mental health professionals and trainees. No awards or grants are explicitly mentioned in the provided materials.